Programmed Death Ligand 1 Expression in Prostate Cancer Cells Is Associated With Deep Changes of the Tumor Inflammatory Infiltrate Composition

Urologic Oncology: Seminars and Original Investigations - United States
doi 10.1016/j.urolonc.2019.02.013
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Elsevier BV

Related search

Programmed Death-Ligand 1 Expression and Its Correlation With Clinicopathological Parameters in Gallbladder Cancer

Journal of Pathology and Translational Medicine
Forensic MedicinePathologyHistology
2020English

Catching Up With Solid Tumor Oncology: What Is the Evidence for a Prognostic Role of Programmed Cell Death-Ligand 1/Programmed Cell Death-1 Expression in B-Cell Lymphomas?

Haematologica
Hematology
2016English

Erratum: Erratum: Expression of Programmed Death Ligand-1 on Tumor Cells Varies Pre and Post Chemotherapy in Non-Small Cell Lung Cancer

Scientific Reports
Multidisciplinary
2016English

P2.04-01 Associations Histological Subtype of Lung Adenocarcinoma and Programmed Death Ligand 1 (PD-L1) Expression in Tumor Cells.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma

Journal of Cancer
Oncology
2017English

JCSE01.14 Effects of Neoadjuvant Chemotherapy on the Expression of Programmed Death Ligand-1 and Tumor Infiltrating Lymphocytes in Lung Cancer Tissues

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MicroRNAs Aid the Assessment of Programmed Death Ligand�1 Expression in Patients With Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Clinicopathological Significance and Prognostic Implication of Programmed Death-1 Ligand 2 Expression in Colorectal Cancer

International Journal of Biological Markers
OncologyCancer ResearchClinical BiochemistryForensic MedicineMedicinePathology
2019English

The Prognostic Role of Immune Checkpoint Markers Programmed Cell Death Protein 1 (PD-1) and Programmed Death Ligand 1 (PD-L1) in a Large, Multicenter Prostate Cancer Cohort

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy